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ABSTRACT
Objective: Microtubule-interfering drugs are commonly used to treat malignant disorders owing to indispensable role of this cytoskeletal element. 
These drugs include paclitaxel, docetaxel, and the Vinca alkaloids; however, owing to their non-selective action and overpolymerizing effects, 
these chemotherapy drugs are confounded by complications with serious toxicity (particularly, peripheral neuropathies, gastrointestinal toxicity, 
myelosuppression, and immunosuppression) (by taxanes) or depolymerizing effects (by Vincas) on microtubules. Thus, there is urgent need to explore 
novel tubulin-binding agents that are significantly effective and comparatively less toxic compared to currently available drugs for the treatment of 
human cancer. The current study focuses fusion of two novel anticancer compounds with low toxicity, i.e., noscapine and triazole to generate a new 
ligand derivative.
Methods: Using computer-aided drug designing approach and molecular docking, molecular interaction of these derivatives with αβ-tubulin 
heterodimer was confirmed and investigated by molecular docking along with dynamics simulation.
Results: A greater affinity of the newly designed ligands for binding to tubulin was predicted. The predictive binding free energy (Gbind,pred) of these 
derivatives (ranging from −10.5178 to −16.8473 kcal/mol) based on linear interaction energy method with a surface generalized born continuum 
salvation model showed improved binding affinity with tubulin as compared to the lead compound. natural α-Noscapine (−5.505 kcal/mol). The 
binding energy of ligand determined using LigX, i.e., MM/GBVI was found to be −23.208 kcal/mol.
Conclusion: We found that designed derivative compounds have better efficacy as compared noscapine and triazole.
Keywords: Noscapine, Triazole, Tubulin heterodimer, Molecular docking, Surface generalized born.
INTRODUCTION
Over the years, various investigations come up with novel therapeutic 
interventions to prevent and/or treat neoplastic disorder and 
associated concerns such as metastasis. Metastasis, spreading of cancer 
lesions from primary site of carcinogenesis to secondary sites, requires 
cellular phenotype transition (epithelial-mesenchymal transition) 
which involves reprogramming cytoskeletal elements [1]. Research 
evidences also report that early stages of malignant transformation 
of neoplastic cells essentially involve alteration of cytoskeletal 
structure of cells [2]. A good proportion of chemotherapeutic agents 
act through interfering microtubule function in transformed cells. 
Among these, tubulin-binding drugs are most successful and constitute 
about 6% of whole therapeutic agents used in clinics. These drugs 
microtubule organization and cause onset of apoptotic mechanisms 
in affected cells, leading to death of cells. Tubulin-binding drugs either 
prevent microtubule polymerization (Vinca alkaloids) or block their 
disassembly (Taxol alkaloids) [2], both leading to cell death. Due to 
less specificity of common tubulin-binding drugs, these agents bind to 
non-specific targets and cause side effects. Inception of resistance and 
availability of target in non-malignant cells also leads to non-specific 
toxicity to normal cells.
Drugs of Vinca and Taxane alkaloids are limited in use due to the 
number of reasons including non-specific toxicities to sensory neurons 
(neuropathies) and digestive tract (gastritis). These drugs also cause 
alopecia and cause wreck myelopoiesis, leading to reduced number 
(cytopenia) and function of cells of immune system. Perturbed cellular 
homeostasis caused by Taxol derivatives and other, many other 
antimitotic drugs affect expression of inflammatory mediators such 
as tumor necrosis factor-alpha and interleukins, and other enzymes 
including nitric oxide synthase and cyclooxygenase. Therefore, it 
becomes imperative to search and screen new drugs or prepare 
derivatives of existing microtubule-binding agents with high specificity, 
less toxicity to normal cells, and other side effects.
Noscapine and triazole have been reported for their MT-binding activity 
with less toxicity. Noscapine is a benzylisoquinoline from plants of the 
poppy family, without painkilling properties. It was discovered by 
French pharmacist and professor Pierre-jean Robiquet, in 1817, from 
opium plant (Papaver somniferum). This agent was primarily used for 
its antitussive (cough suppression) effects [3]. Nevertheless, later, it was 
found to have cytotoxic activity against cancer cells in vitro [4,5]. Due to 
less economic value during the 60s, noscapine was no further analyzed 
for its potential to treat cancer. However, in 1998 [4], anticancer 
potential of noscapine was revisited and analyzed by structure-based 
rationale screening of library of natural compounds sharing structural 
similarities with toxic MT depolymerizing drugs such as colchicines, 
podophyllotoxin, and MTC [2,3,4-trimethoxy-4-acetyl 1,1-biphenyl]. 
Mechanistic studies of noscapine suggest stoichiometric interaction 
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with tubulin, leading to altered conformation causing arrest of cell 
division. Noscapine causes alteration in the steady-state dynamics of 
microtubule assembly before and during metaphase [6].
Triazole (C2H3N3) is a heterocyclic compound having a five-membered 
ring of two carbon atoms and three nitrogen atoms [7]. There are two 
sets of isomer, which differs in their relative positions of the three 
nitrogen atoms. The in vitro studies performed by National Cancer 
Institute (NCI), USA, using a panel of 60 human cancer cell lines (NCI60), 
have shown that 1,2,3 triazole and its derivative poses anticancer 
activity [7]. On an average, it takes about 10–15 years and US$ 500–
800 million to introduce a drug in the market. The use of computer-
aided drug designing to improve the efficacy of the drug discovery 
and will accelerate the development pipeline in the pharmaceutical 
industry. Utilizing tools and applications of bioinformatics for in silico 
development and synthesis of novel drugs for the treatment of various 
diseases will improve the effectiveness with reduced cost and time.
Combinatorial chemistry of many derivatives of noscapine has been 
used along with reasonable speculative prediction model of most 
potent derivative (Figs 1 and 2).  Despite being primary tool for 
speculative calculation, the use of molecular docking alone may result 
in decrease in accuracy. To overcome this issue and find more precise 
predictive information about derivatives, the present study employs 
methodologies to rescore docking results. The present investigation 
exercises molecular mechanics in combination with implicit continuum 
salvation-based scoring function including linear interaction energy 
method with a surface generalized born continuum salvation model, 
generalized born solvation area, etc., in calculating the binding affinity 
between protein and ligands. This scheme was used to find out accurate 
exploratory information about generated derivatives from noscapine 
and triazole, with high efficacy and predictive clinical applicability.
METHODS
In silico screening and ligand preparation
Selection of protein file
The criteria for the selection of protein file (PDB) were that it should 
be from the human source and should have a resolution between 
0.5 and 2.00 A. Thus, PDB file of ABTUBMDS was selected. The PDB 
was downloaded from RCSB protein data bank. The allowable and 
disallowable regions were checked from Ramachandran plot and 
ERRAT report of PDB. The water molecules were removed from the 
monomer. The hydrogens were added to the protein molecule and 
energy was minimized using Merck molecular force field (MMFF).
Ligand preparation
Ligands from the series of 3-(1H-1,2,3-triazole-4-yl)propan-1-ol 
derivative of noscapine (Table 1) to (3R,4S)-5-(1H-1,2,3-triazol-4-yl) 
tetrahydrofuran-2,3,4,triazole derivative of noscapine were prepared 
by the combinatorial approach in MOE Builder (MOE 2008.10). The 
3D structure was energetically minimized using molecular mechanics 
followed by MMFF. All the conformers were then energetically minimized 
up to the RMS gradient of 0.001 and saved in a separate folder. Dielectric 
properties were kept constant. Gradient type used was analytical with 
a maximum number of cycles were 1000. The potential energy of the 
conformers was calculated using MOE potential energy calculator.
LogP value
Log P stands for the partition coefficient of any compound; it measures 
how well a substance partitions between a lipid (oil) and water. It helps 
in understanding the behavior of drug molecules, as different ionic 
species of molecule differ in its physiochemical and biological property 
so it is important to be able to predict which ionic form of the molecule 
is present at the site of action.
 Log P = 1 means 10:1 organic: aqueous
 Log P = 0 means 1:1 organic: aqueous
 Log P =-1 means 1:10 organic: aqueous
Studies have found: (these may not apply to every class of chemicals)
• Optimum CNS penetration around Log P = 2±0.7 (Hansch)
• Optimum Oral absorption around Log P =1.8
• Optimum Intestinal absorption Log P =1.35
• Optimum Colonic absorption Log P = 1.32
• Optimum Sublingual absorption Log P = 5.5
• Optimum Percutaneous Log P=2.6 (and low mw).
Formulation and dosing forms:
• Low Log P (below 0) Injectable
• Medium (0-3) Oral
• High (3-4) Transdermal
• Very High (4-7) Toxic buildup in fatty tissue.
Lipinski’s “rule of 5” for drugs
Chris Lipinski of Pfizer derived an easy to use “rule of thumb” for drug-
likeness in molecules after surveying the world’s marketed drugs.
The rule states that for reasonable absorption:
• Keep H-Bond donors <5 (sum of OH and NHs)
• Keep mW <500
• Log P should be <5
• No more than 10 H bond acceptors.
Energy minimization
The energy minimize application in MOE calculates atomic coordinates 
that are local minima of a molecular energy function. Energy 
minimization comprises finding a set of atomic coordinates that match 
up to a local minimum of the molecular energy function (such as the 
Fig. 1: Scaffold structure of Noscapine with predicted LogP value 
of 0.11±0.68, and 13th carbon atom (marked as green) is the 
position where different triazole group is substituted
Fig. 2: Triazole molecule having different “R” groups at 4th carbon 
atom is substituted to the 13th position of Noscapine. The marked 
green portion is Noscapine joining portion, whereas the blue 
marked is different functional group substitution
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Table 1: (Continued)Table 1: Different functional groups attached to triazole moiety 
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potential energy model). This is done by applying large-scale non-
linear optimization techniques to calculate a conformation (near to the 
starting geometry) for which the forces on the atoms are zero.
Force field optimization
The truncated Newton (TN) method is the most efficient large-scale 
non-linear optimization method known. It exhibits superlinear 
convergence even in highly non-linear conditions. The TN method 
attempts to use curvature information to improve convergence. The 
Newton direction p satisfies:
Gk(xk) p = - grad U(xk)
Where, Gk is the second derivative, or Hessian, of U. These equations 
are called the Newton equations. TN solves the Newton equations 
approximately using an iterative linear equation solver. The iterative 
linear equation solver (based on the Linear Conjugate Gradient method) 
is terminated after a small number of iterations, hence, the name TN. 
The energy of both receptor and ligand is minimized.
Binding site
The different site of ligand binding is detected using “site finder” in 
MOE (MOE 2008.10). The purpose of Site Finder is to calculate possible 
active sites in a receptor from the 3D atomic coordinates of the receptor. 
Site Finder falls into the category of geometric methods since no energy 
models are used. Instead, the relative positions and accessibility of 
the receptor atoms are considered along with a rough classification of 
chemical type. The Site Finder methodology is based on Alpha Shapes 
(AlphaShapes) which are a generalization of convex hulls developed 
in (Edelsbrunner, 1995). About 46 binding sites are detected to which 
binding of ligand is performed.
Surface and mapping
The surfaces and maps application is used to generate visual 
representations of molecular surfaces and can be used to predict the 
preferred locations of ligand atoms (in the absence of the ligand itself). 
The surfaces and maps application is capable of calculating a number 
of molecular surfaces - surfaces near to the Van der Waals or solvent 
accessible surfaces of a molecule. The reentrant surface, or Connolly 
surface, consists of the boundary of the volume of space defined by 
removing all points inside the Van der Waals surface of the spherical 
probe (that represents the solvent) located at all positions for which the 
probe does not contact the Van der Waals volume of a molecule.
Molecular docking
The purpose of the dock application is to search for favorable binding 
configurations between small- and medium-sized ligands and a not 
too flexible macromolecular target, which is usually a protein. For 
each ligand, a number of configurations called poses are generated 
and scored in an effort to determine favorable binding modes. The top 
scoring poses are written out to a database for further analysis. Docking 
simulation was carried out using MOE-Dock. The default parameters 
of MOE-Dock program were used to find the correct conformations of 
the ligands and to obtain minimum energy structures. Ligands were 
allowed to be flexible (rotation of bonds was allowed) in the docking 
algorithm. At the end of docking, the best conformations of the ligands 
were analyzed for their binding interactions. The parameters used for 
docking were as follows: Triangle Matcher placement with timeout 
(300 s) and the number of Return poses=1000, Rescoring1: London 
dG, Retain=10, and force field refinement with a final gradient of 0.01 
with a maximum of 500 iterations. The docking of the 28 CCBs into the 
Fig. 3: ABTUB protein (Receptor molecule) to which hydrogen is 
added, partial charge is added, automated connection and type 
bonds were made, and potential energy is fixed
Fig. 4: Ligand prepared by combinatorial approach, resulting in 
fused pharmacophore derivative of noscapine and triazole
Fig. 5: Molecular property of ligand 1 that showed maximum 
efficacy
Fig. 6: Sites generated by Site Finder in ABTUB protein at alpha‑
position
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receptor was simulated. Each docking simulation was evaluated based 
on the EScore 1 value, which indicates the interaction energy between 
the ligand and the ABTUB ligand-binding site.
Ligand interaction
The ligand interactions application provides a means to visualize 
an active site of a complex in diagrammatic form. The diagram itself 
consists of the selected ligand as the centerpiece, which is drawn 
using the traditional schematic style for molecules. A selection of 
interacting entities, which includes hydrogen-bonded residues, close 
but non-bonded residues, solvent molecules, and ions are drawn about 
the ligand, their positions in 2D being chosen to be representative 
of the observed 3D distances, as well as taking into account esthetic 
considerations. Additional properties such as solvent-accessible 
surface area and the ligand proximity outline are also shown.
LigX energy calculation
LigX is a tool of MOE, which is used to explore protein-ligand 
interaction, and help in manual constructing of the novel compound in 
protein binding sites, and evaluate for binding free energy and affinity 
calculation. In LigX minimization, the receptor atoms near ligand 
(active site) are allowed to move while the receptor atoms far from the 
ligand are held fixed (constrain not to move) but are a subject of tether 
restraints that discourage gross movement. The ligand atom can either 
be free to move or subject to similar tethers specified by a user. When 
we run a tethered energy minimization while the ligand properties are 
displayed, the MM/GBVI binding free energy, affinity, and efficiency will 
be calculated and added to the ligand properties.
RESULTS
Selection of protein file
ABTUB protein file is downloaded from the public database library in 
the PDB format and is then exported to the MOE window where partial 
charges and hydrogen is added, and the potential energy of the receptor 
is fixed using MOE/EDIT function tool (Fig 3).
Ligand preparation
Using combinatorial approach, 20 derivatives of ligand are made. 
Using Molecular Builder tool (MOE 2008.10), ligand is made by adding 
different functional group containing triazole pharmacophore to the 
biaryl pharmacophore skeleton of noscapine (Fig 4). Mainly addition of 
triazole is made at the 13th carbon position in the skeleton of noscapine. 
On the basis of it, about 20 stable structures were drawn.
The energy of all the 20 ligands is minimized and saved in MDB file 
format. However, the ligand 1 [2-(3H-pyrazol-5-yl)ethanol ammoniate 
(1:1) derivative of noscapine] showed maximum activity in overall 
process; hence, the overall property of the ligand (Fig 5) is deduced 
using software ChemDraw, the property generated is as follows:
Site generation
Using Site Finder tool in MOE/compute/site finder, sites are generated 
at alpha center and dummy atoms are created. All the total of 46 
binding sites was generated (Fig 6) to which there is a possibility of 
ligand binding. A list of site is generated to which each and every site is 
saved in MOE format for further use.
Surface and map generation
A Gaussian surface is generated (Figs7-9) at alpha dummies atom 
surrounding the Van der Waals surface of a molecule which is solvent 
in accessible gaps with constant activity, colored by constant properties 
and the transparency of back side is set to more than 75% approximately. 
Using graphics, object manager back and front is made glossy.
Molecular docking
Docking is performed for every ligand to each site and is searched for 
maximum binding energy score value (Figs10 and 11). However, the 
binding energy value of ligand 1 with that of site 2 showed a maximum 
result. Docking is also performed with native triazole and noscapine 
molecule to the same site.
The overall binding score was −16.8035, with retain of 10, then the 
same was exceeded to retain a value of 100, leading to more optimized 
result, i.e., −16.0380. While the overall binding of native noscapine 
to the same site is −12.0377, and that of native triazole molecule is 
−6.7858. Hence, the binding efficacy of the new fused molecule of both 
the native compounds has increased.
Fig. 7: Alpha dummies atom at site 2 of ABTUB receptor and 
molecular surface at that site
Fig. 8: Native Noscapine to site 2
Fig. 9: Native Triazole to site 2
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Ligand interaction
With the help of LigX plot, interaction plot is generated which 
provides a detailed knowledge of the type of bonds and amino acids 
playing a role in the interaction. The interaction report and diagram 
of triazole and noscapine and then the ligand is attached one by one. 
The interacting amino acid in case of native triazole is aspartic acid 
and in case of noscapine is glycine, asparagine, and tyrosine; whereas, 
in case of my ligand 1 [2-(3H-pyrazol-5-yl)ethanol ammoniate (1:1) 
derivative of noscapine] has lysine, glutamine, threonine, asparagine, 
proline, and tyrosine; hence, we can say that the overall binding 
efficiency of the new fused compound has increased from its native 
molecule (Fig 12).
MD simulation
MD simulation is carried out for 200 picosec in two phases, 
i.e., neutral and heating phase. The value calculated out after 
equilibrium simulation is 0.001 and the correlation plot is shown 
below. The basic principle behind MD simulation is that every 
particle has its own vibrational motion and frequency which 
changes from one state to other state and then to a zeroth stage. 
Thus, MD simulation helps in identifying the stability of substance 
at two-point stage and then time back to its zeroth stage and the 
kinetic energy of motion is deduced.
DISCUSSION
The side chain addition is done keeping in mind their partition 
coefficient. The ligand derivative generated was force field energy 
optimized, and the activity was deduced by calculating the binding 
energy and free energy binding (MM/GBVI) of ligand and native 
compound. The result generated has shown an elevated result of 
drug efficacy from its lead compound, i.e., noscapine and triazole. 
Native binding energy generated by docking is in the range of 4 for 
triazole and 11 in the case of noscapine while to an astonishing my 
lead compound showed binding energy in the range of 16, which is 
much more efficient. Similar to that, the MM/GBVI energy of triazole 
cannot be estimated as it is a small molecule with high vibrational 
energy, while that of noscapine showed an energy of −16.272 kcal/
mol and that of my ligand has −23.208 kcal/mol not only this ligand 
interaction showed an increase in binding amino groups but also 
the percent of binding was 13% with aspartic acid for triazole, 12% 
with tyrosine, and 74% with glycine for noscapine. While the ligand 
has 75% with tyrosine, 24% and 21% proline at two sites, 44% with 
aspartic acid, 48% and 57% with threonine from two sites, 73% and 
63% with glutamic acid at two sites, and 18% with lysin, this shows 
that the overall binding affinity has increased and thus the drug can 
be screened for in vivo and ex vivo experiment to support the in silico 
result, and finally, it can be used as one of the oral drugs of cancer 
in future as the logP result shows it to be non-toxic and oral route 
administration is predicted.
CONCLUSION
In the present study a greater affinity of the newly designed ligands 
for binding to tubulin was determined for 2-(3H-pyrazol-5-yl) ethanol 
ammoniate (1:1) derivative of noscapine. The predictive binding 
free energy (Gbind,pred) of all twenty derivatives were ranging from 
−10.5178 to −16.8473 kcal/mol based on linear interaction energy 
Fig. 10: Docking image between ligand 1 [2‑(3H‑pyrazol‑5‑yl)ethanol ammoniate(1:1) derivative of Noscapine] and Receptor[Alpha–Beta 
Tubulin]
Fig. 11: Simulated snapshot of ligand‑protein complex. Where 
black color molecule is Ligand
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method with a surface generalized born continuum salvation model 
which shows improved binding affinity with tubulin as compared to the 
lead compound. Natural α-Noscapine ( −5.505 kcal/mol). Therefore the 
derivatives can be further evaluated for its anticancer activity by using 
invitro and invivo techniques.
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Fig. 12: RMSD plot of LIGAND‑RECEPTOR complex
